Backabrdn Healthcare Investors Overview

abrdn Healthcare Investors EBIT

abrdn Healthcare Investors's EBIT is $270M, above the sector sector average of $-77M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$173.45M

As of Sep 30, 2025

Annual EBIT (TTM)

$272.92M
225.24% YoY

Trailing 12 months ending Sep 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

abrdn Healthcare Investors (HQH) FAQ

As of the most recent data (September 2025), HQH shows a EBIT of $270M. That compares with $84M in the prior-year period — up 225.2% year over year. That is above the sector sector average of $-77M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HQH's EBIT is now $270M (was $84M) — a 225.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether abrdn Healthcare Investors is outperforming or lagging.

The its sector sector average EBIT is about $-77M. abrdn Healthcare Investors is at $270M, which is higher that average. That is roughly 456.6% above the sector mean. Use the comparison chart on this page to see how HQH stacks up against individual peers as well.

Tracking HQH's ebit over time shows whether abrdn Healthcare Investors is scaling, shrinking, or reshaping that part of the business. The current reading is $270M That compares with $84M in the prior-year period — up 225.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has abrdn Healthcare Investors's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $270M) with ownership activity and broader fundamentals.